WESTPORT, Conn., June 23 /PRNewswire/ -- Shares of IMS HEALTH and Nielsen
Media Research begin trading on a "when-issued" basis today on the New York
Stock Exchange and on the Nasdaq National Market. IMS HEALTH and Nielsen
Media Research will be independent, public companies with the spin-off of IMS
HEALTH from Cognizant Corporation on July 1, 1998.
On the New York Stock Exchange, shares of IMS HEALTH will trade under the
symbol "RX," and shares of Nielsen Media Research will trade under the symbol
"NMR." On the Nasdaq National Market, "when-issued" shares of IMS HEALTH will
trade under the symbol "IMSHV," and "when-issued" shares of Nielsen Media
Research will trade under the symbol "NMDRV".
"Regular-way" trading of both issues is expected to begin on July 1, 1998
on the New York Stock Exchange.
IMS HEALTH
IMS HEALTH (NYSE: RX) is the world's leading provider of information
solutions to the pharmaceutical and healthcare industries. With more than
$1 billion in 1997 revenue, IMS HEALTH operates in over 90 countries. IMS
HEALTH is the largest pharmaceutical manufacturer information partner, with
over 40 years' experience in the industry. Key products and services integral
to customer day-to-day operations include: market research for prescription
and over-the-counter pharmaceutical products; sales management information to
optimize sales force productivity; technology enabled selling solutions for
sales and marketing decision-making; and technology systems and information
services that support managed care organizations.
Nielsen Media Research
Nielsen Media Research (NYSE: NMR), the leading source of television
audience measurement services, generated revenue of more than $350 million in
1997. Its National People Meter Service provides audience estimates for all
national programming sources, including broadcast networks, cable networks,
and national syndicators. Local ratings services estimate audiences for each
of 211 television markets in the U.S., including electronic metered service in
40 markets.
Additional information is available at Cognizant's web site:
http://www.cognizantcorp.com.
SOURCE Cognizant Corporation
 back to top
Related links:
http://www.cognizantcorp.com
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Joseph C. Allen of Cognizant Corporation,
203-222-4235
|
